Lupin Limited
LUPIN
Classificação em ações
#2107
Lupin Limited is a pharmaceutical firm dedicated to the creation,... Lupin Limited is a pharmaceutical firm dedicated to the creation, manufacturing, commercialization, and distribution of a wide array of branded and generic medications, biotechnology items, and active pharmaceutical ingredients (APIs). Its comprehensive product portfolio addresses diverse therapeutic categories, including cardiovascular health, diabetes management, asthma, pediatric care, central nervous system disorders, gastrointestinal issues, anti-infectives, nonsteroidal anti-inflammatory drug (NSAID) therapy, respiratory ailments, women's health, and anti-tuberculosis treatments. Beyond its primary offerings, Lupin also supplies biosimilars and over-the-counter (OTC) medicines, alongside specialized pharmaceutical products. The company actively pursues drug discovery and development initiatives focused on oncology, immunology, and metabolic disorders, complementing these efforts with bio-clinical research. Lupin Limited maintains an extensive operational network comprising 18 laboratories, 280 LupiMitra collection centers, and 450 pick-up points. Its global presence extends across numerous countries, such as India, the United States, the United Kingdom, South Africa, Australia, the Philippines, Germany, the Netherlands, Mexico, and Brazil. Originally named Lupin Chemicals Limited, the company adopted its current identity, Lupin Limited, in 2001 following its merger with Lupin Laboratories Limited. Established in 1968, Lupin Limited is based in Mumbai, India.
Preço da ação
$21.43
Valor de mercado
$9.80B
Variação (1 dia)
0.14%
Variação (1 ano)
-2.88%
País
IN
Negociar Lupin Limited (LUPIN)
Categoria
Healthcare
Rácio P/S de Lupin Limited (LUPIN)
Rácio P/S em October 2026 TTM: 3.02
De acordo com os relatórios financeiros mais recentes e o preço das ações da Lupin Limited, o rácio P/S atual (TTM) é 3.02. No final de 2024, o rácio P/S era 3.71.
Histórico do rácio P/S da Lupin Limited de 2004 a 2026
Rácio P/S no final de cada ano
| Ano | Rácio P/S | Alterar |
|---|---|---|
| 2026 (TTM) | 3.02 | -23.28% |
| 2025 | 3.94 | 6.24% |
| 2024 | 3.71 | 107.54% |
| 2023 | 1.79 | -13.98% |
| 2022 | 2.08 | -32.49% |
| 2021 | 3.08 | 74.64% |
| 2020 | 1.76 | -27.16% |
| 2019 | 2.42 | 7.19% |
| 2018 | 2.26 | -41.15% |
| 2017 | 3.84 | -21.44% |
| 2016 | 4.88 | -31.82% |
| 2015 | 7.16 | 90.00% |
| 2014 | 3.77 | 25.69% |
| 2013 | 3.00 | -10.14% |
| 2012 | 3.34 | 2.60% |
| 2011 | 3.25 | 10.85% |
| 2010 | 2.93 | 96.35% |
| 2009 | 1.49 | -0.60% |
| 2008 | 1.50 | -37.81% |
| 2007 | 2.42 | 0.70% |
| 2006 | 2.40 | 37.87% |
| 2005 | 1.74 | -18.90% |
| 2004 | 2.15 | 0.00% |
Rácio P/S de empresas semelhantes ou concorrentes
| Empresa | Rácio P/S | Diferença do rácio P/S | País |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | 133.50% |
IN
|
